The Gastrointestinal Microbial Assay Plus (GI-MAP) is an innovative clinical tool that measures gastrointestinal microbiota DNA from a single stool sample using quantitative polymerase chain reaction (qPCR) technology.
The panel provides insight into microbial balance and potential contributors to gastrointestinal dysfunction. It assesses a wide range of organisms that may influence gut health, including pathogenic bacteria, commensal bacteria, opportunistic organisms, fungi, viruses and parasites, together with key intestinal and immune markers such as calprotectin, secretory IgA and pancreatic elastase. This comprehensive analysis helps practitioners understand how microbial patterns may relate to digestive symptoms or broader health presentations.
Results are interpreted alongside clinical history, digestive function and environmental factors. Quantitative reporting allows comparison over time to help review changes in microbial patterns following dietary, lifestyle or therapeutic interventions. Add-ons available include zonulin, StoolOMX (bile acids and short-chain fatty acids) and gluten peptide.